Promise Bio CEO dishes on why Pfizer, AstraZeneca are backing its quest to crack autoimmune trial-and-error

Fostering AI Solutions To Revolutionize Drug Discovery Startups

Post-hype, pre-value: The real AI-pharma shift starts now

​Study validates DenovAI’s platform for programmable de novo-designed protein therapeutics

AI-First Business Models Seek to Reshape Drug Discovery

AION Labs Launches 2025 Global Call for Applications: Generative AI for Novel Target Combinations

Inside AION Labs, the AI-focused venture studio with the backing of AstraZeneca, Pfizer, AWS and other power players

What to look for in a biotech incubator

Podcast: About Medicines, Innovation and the Future of Biotech with AION Labs CEO (Hebrew)

8200Bio BioNation Podcast with AION Labs CEO